ABBOTT LABORATORIES

(ABT)
  Report
Delayed Nyse  -  04:03 2022-08-10 pm EDT
110.27 USD   +2.19%
08/04Abbott and Weightwatchers Partner to Support People Living with Diabetes in Attaining Their Health Goals
CI
08/02ABBOTT LABORATORIES Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
08/01Abbott Laboratories Announces Executive Changes
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart ABBOTT LABORATORIES
Upcoming events on ABBOTT LABORATORIES
10/19/22 Q3 2022 Earnings Release (Projected)
01/25/23 FY 2022 Earnings Release (Projected)
04/19/23 Q1 2023 Earnings Release (Projected)
07/20/23 Interim 2023 Earnings Release (Projected)
Past events on ABBOTT LABORATORIES
07/20/22 | 09:00am Interim 2022 Earnings Call
07/20/22 | 07:30am Interim 2022 Earnings Release
07/14/22 Ex-dividend day for
06/05/22 American Diabetes Association Scientific Conference
04/29/22 | 10:00am Annual General Meeting
04/27/22 Advanced Technologies & Treatments for Diabetes Congress
04/20/22 | 09:00am Q1 2022 Earnings Call
04/20/22 | 07:30am Q1 2022 Earnings Release
04/13/22 Ex-dividend day for
01/26/22 | 09:00am FY 2021 Earnings Call
Past dividends on ABBOTT LABORATORIES
07/14/22 Quarterly 0.47 USD
04/13/22 Quarterly 0.47 USD
01/13/22 Quarterly 0.47 USD
10/14/21 Quarterly 0.45 USD
07/14/21 Quarterly 0.45 USD
04/14/21 Quarterly 0.45 USD
01/14/21 Quarterly 0.45 USD
10/14/20 Quarterly 0.36 USD
07/14/20 Quarterly 0.36 USD
04/14/20 Quarterly 0.36 USD
Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
27 390
27 194
0,72%
30 578
30 652
-0,24%
31 904
31 846
0,18%
34 608
33 854
2,2%
43 075
42 206
2,1%
 
42 541
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
7 022
6 968
0,78%
9 833
7 757
27%
8 188
8 266
-0,94%
9 204
8 954
2,8%
12 815
12 584
1,8%
 
11 978
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
5 976
6 010
-0,56%
6 555
6 616
-0,91%
7 110
7 149
-0,55%
8 009
7 841
2,1%
11 324
11 010
2,8%
 
10 542
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
2 231
3 867
-42%
2 873
2 782
3,3%
4 077
3 920
4,0%
4 968
4 052
23%
8 211
7 728
6,2%
 
7 657
 
Net income
M $
Released
Forecast
Spread
353
1 805
-80%
2 334
2 380
-1,9%
3 687
3 655
0,87%
4 471
4 415
1,3%
7 071
6 738
4,9%
 
6 855
 
EPS
$
Released
Forecast
Spread
0,20
1,00
-80%
1,31
1,34
-2,5%
2,06
2,10
-1,7%
2,49
2,45
1,7%
3,94
3,80
3,8%
 
3,85
 
Announcement Date01/24/201801/23/201901/22/202001/27/202101/26/2022-
Quarterly results
Fiscal Period : December2021 Q22021 Q32021 Q42022 Q12022 Q22022 Q3
Sales
M $
Released
Forecast
Spread
10 223
9 673
5,7%
10 928
9 564
14%
11 468
10 697
7,2%
11 895
10 996
8,2%
11 257
10 400
8,2%
 
9 594
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
2 918
2 661
9,7%
3 369
2 404
40%
3 263
2 954
10%
4 247
3 434
24%

2 762
 
 
2 316
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
2 548
2 233
14%
3 042
2 089
46%
2 894
2 598
11%
3 620
3 058
18%
2 985
2 394
25%
 
1 941
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread


 


 


 


 


 
 

 
Net income
M $
Released
Forecast
Spread
1 189
1 096
8,5%
2 100
1 137
85%
1 989
1 555
28%
2 447
2 277
7,5%
2 018
1 433
41%
 
1 093
 
EPS
$
Released
Forecast
Spread
0,66
0,66
-0,69%
1,17
0,67
74%
1,11
0,89
24%
1,37
1,22
12%
1,14
0,79
44%
 
0,63
 
Announcement Date07/22/202110/20/202101/26/202204/20/202207/20/2022-
Previous year Next Year
Upcoming sector events for ABBOTT LABORATORIES
More events
Past sector events for ABBOTT LABORATORIES
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise